Pre-clinical comparison of approaches to increasing the immunogenicity of CA125 (MUC16) DNA vaccines

被引：0
|
作者：
Ragupathi, Govind
Koide, Fusataka
Yin, Beatrice Wt
Lloyd, Kenneth O.
Hannaman, Drew
Livingston, Philip O.
机构：
[1] Mem Sloan Kettering, New York, NY USA
[2] Ichor Med Syst Inc, San Diego, CA USA
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1406
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Determination and analysis of HLA-A2 epitopes on ovarian cancer antigen CA125 (MUC16)
    Schultes, Birgit C.
    Hou, Fuxiang
    Nicodemus, Christopher F.
    JOURNAL OF IMMUNOLOGY, 2006, 176 : S268 - S269
  • [42] Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125)
    Chauhan, Subhash C.
    Singh, Ajay P.
    Ruiz, Fernanda
    Johansson, Sonny L.
    Jain, Maneesh
    Smith, Lynette M.
    Moniaux, Nicolas
    Batra, Surinder K.
    MODERN PATHOLOGY, 2006, 19 (10) : 1386 - 1394
  • [43] Pathobiological role of MUC16 mucin(CA125) in ovarian cancer: Much more than a tumor biomarker
    Alain Piché
    World Journal of Obstetrics and Gynecology, 2016, (01) : 39 - 49
  • [44] Solution structure of the SEA domain from the murine homologue of ovarian cancer antigen CA125 (MUC16)
    Maeda, T
    Inoue, M
    Koshiba, S
    Yabuki, T
    Aoki, M
    Nunokawa, E
    Seki, E
    Matsuda, T
    Motoda, Y
    Kobayashi, A
    Hiroyasu, F
    Shirouzu, M
    Terada, T
    Hayami, N
    Ishizuka, Y
    Shinya, N
    Tatsuguchi, A
    Yoshida, M
    Hirota, H
    Matsuo, Y
    Tani, K
    Arakawa, T
    Carninci, P
    Kawai, J
    Hayashizaki, Y
    Kigawa, T
    Yokoyama, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (13) : 13174 - 13182
  • [45] Crystal structure of a human MUC16 SEA domain reveals insight into the nature of the CA125 tumor marker
    White, Brandy
    Patterson, Michelle
    Karnwal, Saloni
    Brooks, Cory L.
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2022, 90 (05) : 1210 - 1218
  • [46] Immunotherapy for KRAS Positive Lung Adenocarcinoma: Mesothelin and CA125 (MUC16) Are Cancer-Antigen Targets
    Hristov, Boris
    Eguchi, Takashi
    Chintala, Navin
    Lu, Shaohua
    Bott, Matthew
    Travis, William
    Jones, David
    Adusumilli, Prasad
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1457 - S1457
  • [47] The MUC16/CA125 gene inhibits apoptosis in SK-OV-3 ovarian carcinoma cells
    Diaz, J. P.
    Dos Santos, L. A.
    Rosales, N.
    Thapi, D.
    Ma, X.
    Yan, X. J.
    Spriggs, D. R.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S42 - S42
  • [48] Dual-Fluorescence Isogenic High-Content Screening for MUC16/CA125 Selective Agents
    Rao, Thapi D.
    Rosales, Nestor
    Spriggs, David R.
    MOLECULAR CANCER THERAPEUTICS, 2011, 10 (10) : 1939 - 1948
  • [49] MUC16/CA125 in the Context of Modular Proteins with an Annotated Role in Adhesion-Related Processes: In Silico Analysis
    Jankovic, Miroslava
    Mitic, Ninoslav
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (08): : 10387 - 10400
  • [50] A Revised Molecular Model of Ovarian Cancer Biomarker CA125 (MUC16) Enabled by Long-read Sequencing
    Wang, Chien-Wei
    Weaver, Simon D.
    Boonpattrawong, Nicha
    Schuster-Little, Naviya
    Patankar, Manish
    Whelan, Rebecca J.
    CANCER RESEARCH COMMUNICATIONS, 2024, 4 (01): : 253 - 263
12345